Table 2.
Analysis of HOMA‐IR based on BDNF Met carrier and Statin Status.
| Subject groups | Schizophrenia spectrum disorders | Bipolar disorder | Combined sample | |||
|---|---|---|---|---|---|---|
| HOMA‐IR ± s.d. | p‐value | HOMA‐IR ± s.d. | p‐value | HOMA‐IR ± s.d. | p‐value | |
| BDNF 66ValVal Genotype | 5.10 ± 0.400 | 0.046 | 6.04 ± 0.621 | 0.7 | 5.52 ± 0.352 | 0.3 |
| BDNF 66Met Allele Carriers | 6.63 ± 0.642 | 5.47 ± 1.12 | 6.18 ± 0.594 | |||
| BDNF Val66 with or without Statins and BDNF 66Met without Statins | 5.30 ± 0.350 | 0.016 | 5.99 ± 0.553 | 0.5 | 5.60 ± 0.312 | 0.2 |
| BDNF 66Met Carriers and Currently Taking a Statin | 8.45 ± 1.24 | 3.99 ± 2.74 | 7.15 ± 1.25 | |||